Nanosonics Ltd

AU:NAN Australia Medical Instruments & Supplies
Market Cap
$644.25 Million
AU$1.04 Billion AUD
Market Cap Rank
#9824 Global
#112 in Australia
Share Price
AU$3.43
Change (1 day)
+0.88%
52-Week Range
AU$3.24 - AU$5.02
All Time High
AU$8.25
About

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It… Read more

Nanosonics Ltd (NAN) - Net Assets

Latest net assets as of June 2025: AU$209.91 Million AUD

Based on the latest financial reports, Nanosonics Ltd (NAN) has net assets worth AU$209.91 Million AUD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$272.48 Million) and total liabilities (AU$62.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$209.91 Million
% of Total Assets 77.04%
Annual Growth Rate N/A
5-Year Change 54.84%
10-Year Change 270.45%
Growth Volatility 144.79

Nanosonics Ltd - Net Assets Trend (2005–2025)

This chart illustrates how Nanosonics Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Nanosonics Ltd (2005–2025)

The table below shows the annual net assets of Nanosonics Ltd from 2005 to 2025.

Year Net Assets Change
2025-06-30 AU$209.91 Million +15.21%
2024-06-30 AU$182.20 Million +11.19%
2023-06-30 AU$163.86 Million +18.15%
2022-06-30 AU$138.69 Million +2.30%
2021-06-30 AU$135.57 Million +9.13%
2020-06-30 AU$124.23 Million +12.85%
2019-06-30 AU$110.08 Million +16.73%
2018-06-30 AU$94.30 Million +8.08%
2017-06-30 AU$87.25 Million +53.98%
2016-06-30 AU$56.66 Million +26.83%
2015-06-30 AU$44.68 Million +118.62%
2014-06-30 AU$20.43 Million -5.86%
2013-06-30 AU$21.71 Million -16.52%
2012-06-30 AU$26.00 Million +81.76%
2011-06-30 AU$14.31 Million -39.34%
2010-06-30 AU$23.58 Million +44.57%
2009-06-30 AU$16.31 Million -33.58%
2008-06-30 AU$24.56 Million -21.58%
2007-06-30 AU$31.32 Million +643.70%
2006-06-30 AU$4.21 Million +668.29%
2005-06-30 AU$-741.00K --

Equity Component Analysis

This analysis shows how different components contribute to Nanosonics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 5839000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Retained Earnings AU$58.39 Million 27.82%
Common Stock AU$114.86 Million 54.72%
Other Comprehensive Income AU$36.66 Million 17.47%
Total Equity AU$209.91 Million 100.00%

Nanosonics Ltd Competitors by Market Cap

The table below lists competitors of Nanosonics Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nanosonics Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 182,202,000 to 209,910,000, a change of 27,708,000 (15.2%).
  • Net income of 20,676,000 contributed positively to equity growth.
  • Share repurchases of 310,000 reduced equity.
  • New share issuances of 310,000 increased equity.
  • Other comprehensive income increased equity by 6,722,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$20.68 Million +9.85%
Share Repurchases AU$310.00K -0.15%
Share Issuances AU$310.00K +0.15%
Other Comprehensive Income AU$6.72 Million +3.2%
Other Changes AU$310.00K +0.15%
Total Change AU$- 15.21%

Book Value vs Market Value Analysis

This analysis compares Nanosonics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.05x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 14.65x to 5.05x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-06-30 AU$0.23 AU$3.43 x
2008-06-30 AU$0.13 AU$3.43 x
2009-06-30 AU$0.08 AU$3.43 x
2010-06-30 AU$0.11 AU$3.43 x
2011-06-30 AU$0.06 AU$3.43 x
2012-06-30 AU$0.11 AU$3.43 x
2013-06-30 AU$0.08 AU$3.43 x
2014-06-30 AU$0.08 AU$3.43 x
2015-06-30 AU$0.17 AU$3.43 x
2016-06-30 AU$0.20 AU$3.43 x
2017-06-30 AU$0.29 AU$3.43 x
2018-06-30 AU$0.31 AU$3.43 x
2019-06-30 AU$0.36 AU$3.43 x
2020-06-30 AU$0.41 AU$3.43 x
2021-06-30 AU$0.44 AU$3.43 x
2022-06-30 AU$0.45 AU$3.43 x
2023-06-30 AU$0.53 AU$3.43 x
2024-06-30 AU$0.59 AU$3.43 x
2025-06-30 AU$0.68 AU$3.43 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nanosonics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 9.85%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 10.39%
  • • Asset Turnover: 0.73x
  • • Equity Multiplier: 1.30x
  • Recent ROE (9.85%) is above the historical average (-9.93%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2007 -18.21% -67705.65% 0.00x 1.07x AU$-8.84 Million
2008 -29.10% -642.72% 0.04x 1.04x AU$-9.60 Million
2009 -53.67% -2833.01% 0.02x 1.08x AU$-10.39 Million
2010 -34.65% -1071.04% 0.03x 1.06x AU$-10.53 Million
2011 -78.39% -499.07% 0.13x 1.18x AU$-12.64 Million
2012 -17.99% -38.04% 0.34x 1.41x AU$-7.28 Million
2013 -26.57% -38.71% 0.44x 1.55x AU$-7.94 Million
2014 -12.75% -12.12% 0.64x 1.64x AU$-4.65 Million
2015 -12.22% -24.58% 0.37x 1.35x AU$-9.93 Million
2016 0.22% 0.29% 0.63x 1.20x AU$-5.54 Million
2017 29.98% 38.75% 0.68x 1.14x AU$17.43 Million
2018 6.10% 9.47% 0.56x 1.16x AU$-3.68 Million
2019 12.36% 16.13% 0.65x 1.18x AU$2.59 Million
2020 8.16% 10.20% 0.67x 1.19x AU$-2.29 Million
2021 6.33% 8.42% 0.62x 1.21x AU$-4.98 Million
2022 2.70% 3.13% 0.62x 1.39x AU$-10.13 Million
2023 12.13% 11.87% 0.74x 1.38x AU$3.50 Million
2024 7.12% 7.56% 0.72x 1.30x AU$-5.25 Million
2025 9.85% 10.39% 0.73x 1.30x AU$-315.00K

Industry Comparison

This section compares Nanosonics Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $11,625,473
  • Average return on equity (ROE) among peers: -11.98%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Nanosonics Ltd (NAN) AU$209.91 Million -18.21% 0.30x $545.85 Million
Austco Healthcare Ltd (AHC) $19.30 Million 17.74% 0.41x $56.41 Million
Osteopore Ltd (OSX) $5.37 Million -67.39% 0.12x $740.73K
SDI Ltd (SDI) $10.44 Million -4.32% 0.36x $34.55 Million
Trajan Group Holdings Ltd (TRJ) $11.39 Million 6.06% 1.69x $17.96 Million